Related Experiment Video

Updated: Oct 18, 2025

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.2K

Targeting Tumor Cells with Nanoparticles for Enhanced Co-Drug Delivery in Cancer Treatment

Wen-Ying Huang1, Chih-Ho Lai2, Shin-Lei Peng3

  • 1Department of Applied Cosmetology, Hung-Kuang University, Taichung 433304, Taiwan.

Pharmaceutics
|September 28, 2021
PubMed

Insights

New nanoparticles loaded with epigallocatechin-3-gallate (EGCG) and doxorubicin (DX) show promise for gastric cancer (GC) treatment. This novel nanomedicine effectively targets GC cells, enhancing anti-cancer effects and reducing organ injury in preclinical models.

Area of Science:

  • Biomedical Engineering
  • Nanomedicine
  • Oncology

Background:

  • Gastric cancer (GC) remains a significant global health challenge with limited effective therapeutic options.
  • Nanoparticle (NP)-based drug delivery systems offer a promising avenue for developing novel GC treatments.
  • Targeted NPs can enhance drug delivery to cancer cells, improving therapeutic efficacy and reducing side effects.

Purpose of the Study:

  • To develop and evaluate a novel nanoparticle system for targeted gastric cancer therapy.
  • To investigate the synergistic anti-cancer effects of epigallocatechin-3-gallate (EGCG) and doxorubicin (DX) delivered via nanoparticles.
  • To assess the in vivo efficacy and safety of the developed EGCG/DX-loaded NPs in a gastric tumor mouse model.

Main Methods:

  • Encapsulation of EGCG and low-concentration DX into fucoidan and hyaluronic acid-based NPs conjugated with d-alpha-tocopherylpoly (ethylene glycol) succinate.
  • Targeting of P-selectin and CD44 receptors expressed on gastric cancer cells.
  • In vitro evaluation of NP binding, cellular uptake, and anti-cancer effects compared to free drug combinations.
  • In vivo assessment of therapeutic efficacy and organ toxicity in an orthotopic gastric tumor mouse model.

Main Results:

  • The developed EGCG/DX-loaded NPs effectively targeted and bound to gastric cancer cells, enhancing cellular uptake.
  • The NP-based drug delivery demonstrated superior anti-cancer effects compared to the free EGCG/DX combination solution.
  • In vivo studies showed significant inhibition of gastric tumor progression with no observed organ injury.

Conclusions:

  • The EGCG/DX-NP system represents a promising nanomedicine-based approach for gastric cancer treatment.
  • This novel system enhances combination chemotherapy efficacy through targeted delivery and synergistic drug action.
  • Further development of this nanomedicine platform could lead to improved therapeutic strategies for gastric cancer.
Keywords:
combination chemotherapyd-alpha-tocopherylpoly (ethylene glycol) succinatefucoidangastric cancernanoparticle

More Related Videos

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.2K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
741
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K